Moving towards IMPROVED drug-free remission

被引：1
作者：
Bykerk, Vivian P. [1 ,2 ]
机构：
[1] Weill Cornell Med Coll, New York, NY 10065 USA
[2] Hosp Special Surg, Inflammatory Arthrit Ctr, 535 E 70th St, New York, NY 10021 USA
来源：
NATURE REVIEWS RHEUMATOLOGY | 2018年 / 14卷 / 04期
基金：
加拿大健康研究院; 美国国家卫生研究院;
关键词：
RHEUMATOID-ARTHRITIS;
D O I：
10.1038/nrrheum.2018.49
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The newly published 5-year outcomes of the IMPROVED trial demonstrate the feasibility of achieving long-term drug-free remission in early rheumatoid arthritis (RA). These findings raise the bar and support the use of a remission induction and maintenance approach, particularly in patients presenting with early joint inflammation consistent with early RA.
引用
收藏
页码：193 / 194
页数：2
相关论文
共 50 条
  • [1] Drug-free remission: is it already possible?
    van den Broek, Marianne
    Huizinga, Tom W. J.
    Dijkmans, Ben A. C.
    Allaart, Cornelia F.
    CURRENT OPINION IN RHEUMATOLOGY, 2011, 23 (03) : 266 - 272
  • [2] THERAPY Challenging the course of RA: time for drug-free remission?
    Aletaha, Daniel
    NATURE REVIEWS RHEUMATOLOGY, 2010, 6 (08) : 442 - 443
  • [3] Spontaneous, drug-induced, and drug-free remission in peripheral and axial spondyloarthritis
    Poddubnyy, Denis
    Gensler, Lianne S.
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2014, 28 (05): : 807 - 818
  • [4] Promise of rheumatoid arthritis therapy: From clinical deep remission to drug-free remission
    Hou, Yuke
    Peng, Yuanhong
    Jin, Jiayang
    Li, Zhanguo
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2025, 39 (01):
  • [5] Predicting drug-free remission in rheumatoid arthritis: A prospective interventional cohort study
    Baker, Kenneth F.
    Skelton, Andrew J.
    Lendrem, Dennis W.
    Scadeng, Adam
    Thompson, Ben
    Pratt, Arthur G.
    Isaacs, John D.
    JOURNAL OF AUTOIMMUNITY, 2019, 105
  • [6] Inducibility or predestination? Queries and concepts around drug-free remission in rheumatoid arthritis
    D'Onofrio, Bernardo
    van der Helm-van Mil, Annette
    Huizinga, Tom W. J.
    van Mulligen, Elise
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (02) : 217 - 225
  • [7] Defining the Optimal Strategies for Achieving Drug-Free Remission in Rheumatoid Arthritis: A Narrative Review
    Gul, Hanna
    Harnden, Kate
    Saleem, Benazir
    HEALTHCARE, 2021, 9 (12)
  • [8] On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis
    Vivian P. Bykerk
    Gerd R. Burmester
    Bernard G. Combe
    Daniel E. Furst
    Tom W. J. Huizinga
    Harris A. Ahmad
    Paul Emery
    Rheumatology International, 2018, 38 : 2225 - 2231
  • [9] On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis
    Bykerk, Vivian P.
    Burmester, Gerd R.
    Combe, Bernard G.
    Furst, Daniel E.
    Huizinga, Tom W. J.
    Ahmad, Harris A.
    Emery, Paul
    RHEUMATOLOGY INTERNATIONAL, 2018, 38 (12) : 2225 - 2231
  • [10] Two-year results of disease activity score (DAS)-remission-steered treatment strategies aiming at drug-free remission in early arthritis patients (the IMPROVED-study)
    Heimans, Lotte
    Akdemir, Gulsah
    Wevers-de Boer, Kirsten V. C.
    Goekoop-Ruiterman, Yvonne P.
    Molenaar, Esmeralda T.
    van Groenendael, Johannes H. L. M.
    Peeters, Andreas J.
    Steup-Beekman, Gerda M.
    Lard, Leroy R.
    de Sonnaville, Peter B. J.
    Grillet, Bernard A. M.
    Huizinga, Tom W. J.
    Allaart, Cornelia F.
    ARTHRITIS RESEARCH & THERAPY, 2016, 18
12345